U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07843004) titled 'Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease' on Sept. 21.
Brief Summary: Doctors are testing a new tool called EchoNext to see if it can help find heart problems earlier. EchoNext looks at the heart's electrical test, called an ECG, and uses artificial intelligence (AI) to check for signs of structural heart disease (SHD). SHD includes conditions like weak heart pumping, heart valve problems, or extra thickening of the heart muscle. These problems are common but often go undiagnosed until they cause serious issues like heart failure or stroke.
The main questions this study will answer are:
Can EchoNext aler...